It Takes a Village

07/16/2020

The environment around plasma collection, plasma research, and plasma therapies is vast and immense. So here’s a primer of some partners in the critical, life-saving work of plasma:

The American College of Allergy, Asthma, and Immunology (ACAAI) and American Academy of Allergy, Asthma & Immunology (AAAAI) are both physician membership organizations. As such, they provide professional training and a library of resources related to plasma protein therapies and their use.

American Plasma Users Coalition (APLUS) is a membership organization comprised of patient advocacy organizations that represent individuals who are dependent on plasma protein therapies. APLUS advocates for public policy, regulations, directives, guidelines, and recommendations that improve access to therapy and treatment.

The Center for Biologics Evaluation and Research (CBER), a part of the U.S. Food & Drug Administration (FDA), is responsible for the safety of blood and blood components, which includes the plasma collection process. This may include safety inspections of facilities, regulations and protocols, and promoting an adequate supply of blood and blood products. Clinical Immunologic Society (CIS) fosters developments in science and the practice of clinical immunology. Their focus on scientific advancements, medical research, and clinical practice often includes promoting the use of biologic therapies and treatments.

IG Living is a periodical publication focused on immunoglobulin therapies published by FFF Enterprises.  With 30,000 subscribers, this magazine provides information about clinical research, treatments, and immunoglobulin therapy.

The Immunoglobulin National Society (IgNS) is a professional membership organization for healthcare professionals that provides professional education and certification and maintains standards of practice for immunoglobulin (Ig) therapies. They recently launched a plasma donation initiative entitled It’s My Turn.

iPlasma is a blood and plasma technology start-up, founded in 2018. Their website features information on donation centers and hosts a regularly-scheduled podcast as well as a plasma center location tool.

Plasma Protein Therapeutics Association (PPTA) is a global organization representing private plasma protein therapy manufacturers, whose products treat a variety of rare diseases and serious medical conditions. As part of their mission, they advocate for affordable therapies, engage with regulatory agencies, collaborate with patient advocacy organizations, and house an interactive map for individuals looking for donation centers.

Join the Plasma Hero online community

Subscribe to Plasma Hero to get important news and updates that include hero stories and ways to get involved!

Sign up

News & Updates

Get the latest information on plasma through our news and updates. Featuring: Scientific discoveries, plasma supply, industry-related coverage, policy and legislation, and more!

Those with alpha-1 antitrypsin deficiency depend on plasma donations

07/16/2024

Many rare, chronic conditions with no known cures, including alpha-1 antitrypsin deficiency, can be managed with augmentation therapy treatments made from donated plasma.
Read More

Increase plasma supply by harmonizing state regulations

06/11/2024

States with regulations exceeding FDA standards create barriers for plasma centers, donors, and patients.
Read More

Plasma is a vital weapon against tetanus and rabies

05/20/2024

While tetanus and rabies are fairly rare in the United States today, these deadly diseases still pose a major global health threat. However, plasma-derived antibody products play a crucial role in treating these illnesses around the world.
Read More

Congressional Plasma Caucus formed to address concerns of constituents

04/25/2024

Members of the congressional Plasma Caucus provide a venue to educate legislators on important legislation to provide access to patients who rely on immunoglobulin (Ig) therapy.
Read More

Plasma demand is on the rise because of new patients and products

03/26/2024

The need for plasma is forecasted to increase since more patients are being diagnosed with current and newly discovered rare conditions as well as additional indications being approved for plasma medications.
Read More

Busting common plasma donation myths

02/21/2024

Misconceptions about plasma donation, such as that it is bad for your health, lead to undue misapprehensions.
Read More